Citations

Institution: Mayo Clinic Clear

Showing 10 of 108083 citations.

Why Kipchoge’s spectacular Berlin run sets the stage for faster marathons
Joyner, Michael J.

No container title available | August 26, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64628/aaj.ynwytdw59 Get It

Validation of an Automated CT Image Analysis in the Prevention of Urinary Stones with Hydration Trial
Tasian, Gregory E., Harper, Jonathan D. , Sivalingam, Sri , Logan, Joey, Al‐Khalidi, Hussein R. , Lieske, John C., Selman-Fermin, Antoine, Desai, Alana , Lai, H. Henry , Kırkalı, Ziya , Scales, Charles D , Tasian, Gregory E. , Tasian, Gregory E., Maalouf, Naim M. , Lieske, John C. , Scales, Charles D. , Fan, Yong

Journal of Endourology | August 26, 2025 | Volume: 39 | Issue: 9 | Pages: 953-959

10.1089/end.2024.0582 | PMID 40854610 Get It

Introduction and Objective: Kidney stone growth and new stone formation are common clinical trial endpoints and are associated with future symptomatic events. To date, a manual review of CT scans has been required to assess stone growth and new stone formation, which is laborious. We validated the performance of a software algorithm that automatically identified, registered, and measured stones over longitudinal CT studies. Methods: We validated the performance of a pretrained machine learning algorithm to classify stone outcomes on longitudinal CT scan images at baseline and at the end of the 2-year follow-up period for 62 participants aged >18 years in the Prevention of Urinary Stones with Hydration (PUSH) randomized controlled trial. Stones were defined as an area of voxels with a minimum linear dimension of 2 mm that was higher in density than the mean plus 4 standard deviations of all nonnegative HU values within the kidney. The four outcomes assessed were: (1) growth of at least one existing stone by ≥2 mm, (2) formation of at least one new ≥2 mm stone, (3) no stone growth or new stone formation, and (4) loss of at least one stone. The accuracy of the algorithm was determined by comparing its outcomes to the gold standard of independent review of the CT images by at least two expert clinicians. Results: The algorithm correctly classified outcomes for 61 paired scans (98.4%). One pair that the algorithm incorrectly classified as stone growth was a new renal artery calcification on end-of-study CT. Conclusions: An automated image analysis method validated for the prospective PUSH trial was highly accurate for determining clinical outcomes of new stone formation, stone growth, stable stone size, and stone loss on longitudinal CT images. This method has the potential to improve the accuracy and efficiency of clinical care and endpoint determination for future clinical trials.
Cara baru terapi penyakit jiwa: berikan pekerjaan kepada penderita
Puspitasari, Ajeng J.

No container title available | August 26, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64628/aan.ce49xvwuf Get It

Comparative Outcomes of Septal Extension versus Columellar Strut Grafts for Nasal Tip Stabilization and Positioning in Rhinoplasty: A Systematic Review and Meta-analysis
Ozgenc, Ismail , Vankayalapati, Dilip K , Bayan, Laith , Lee, Sum-Yu Christina , Huynh, Kelson, Waqasi, Annah, Nakanishi, Hayato, Alzoubi, Dana, Huynh, Kelson, Navaratnam, Annakan Victor

Facial Plastic Surgery | August 25, 2025 | Volume: 42 | Issue: 03 | Pages: 396-408

10.1055/a-2689-1496 | PMID 40854551 Get It

Abstract Columellar strut graft (CSG) and septal extension graft (SEG) are commonly used in septorhinoplasty for nasal tip support. We aimed to systematically review and compare CSG and SEG in achieving a desired nasolabial angle (NLA) and Goode's ratio (GR). Several databases were systematically searched from inception to August 2024. A two-arm meta-analysis of the pooled means was conducted with a random-effects model. This review was registered in PROSPERO (CRD42024574909). Eligible studies included primary septorhinoplasty patients (≥17 years) receiving CSG or SEG. Eight studies met eligibility criteria including 256 CSG and 371 SEG patients. Intergroup comparison of long-term postoperative NLA favored SEG (p < 0.05) while GR showed no differences. However, SEG patients had significant improvement in GR postoperatively (p < 0.05), unlike CSG patients. SEG may provide superior long-term nasal tip rotation and projection stability.
Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease Optic Neuritis With Venous Stasis Retinopathy
Saify, Mariya , Hur, Minjun, Guido, Fiorella Stefania, Selcen, Duygu , Chen, John J. , Chen, John J , Guido, Fiorella Stefania

Neurology | August 25, 2025 | Volume: 105 | Issue: 6 | Pages: No page available

10.1212/wnl.0000000000214038 | PMID 40854174 Get It

Digital Health in Stroke Neurology: Current State and Future Directions
Sohutskay, David O , Tvrdá, Lucie , Keser, Zafer , Keser, Zafer

Stroke | August 25, 2025 | Volume: 56 | Issue: 9 | Pages: No page available

10.1161/strokeaha.124.049469 | PMID 40854037 Get It

Evolving Role of Plasma Phosphorylated Tau 217 in Alzheimer Disease—Time for Tau
Graff‐Radford, Jonathan , Binks, Sophie

JAMA Neurology | August 25, 2025 | Volume: 82 | Issue: 10 | Pages: 981

10.1001/jamaneurol.2025.2972 | PMID 40853649 Get It

Big Data in Neurosurgery: A Guideline on Data Structures, Machine Learning Models, and Ethical Considerations
Singh, Rohin , Kassis, George, Sbaih, Omar, Li, Herman , Lawton, Michael T. , Gottfried, Oren N., Bydon, Mohamad , Stone, Jonathan, Singh, Rohin , Sbaih, Omar I. , Shahrestani, Shane

Operative Neurosurgery | August 25, 2025 | Volume: 30 | Issue: 6 | Pages: 819-826

10.1227/ons.0000000000001751 | PMID 40853158 Get It

Artificial intelligence (AI) is reshaping neurosurgery, offering unprecedented opportunities to enhance diagnostics, personalize treatment, and predict outcomes. At the heart of this transformation is the ability to effectively harness big data (BD) within the electronic medical record. Understanding these data structures is essential for making sense of the vast volumes of information generated in modern neurosurgical practice. Equally important are the machine learning (ML) models driving these advancements. From supervised learning and convolutional neural networks to generative AI, these tools are already making a mark in areas such as brain tumor segmentation and spine surgery outcome predictions. Their versatility highlights the potential of ML to complement clinical expertise and streamline decision-making in neurosurgery. However, adopting BD and ML also brings ethical challenges that cannot be ignored. Bias in algorithms threatens to reinforce health disparities, whereas concerns about data privacy demand vigilance in handling sensitive patient information. In addition, the question of liability looms large as ML increasingly influences clinical decisions. The aim of the study was to provide a roadmap for neurosurgeons navigating the evolving intersection of BD, ML, and ethical responsibility in the AI era.
Outcomes Associated With SGLT2 Inhibitor Use Following Acute Myocardial Infarction Without Heart Failure: A Propensity-Matched Study
Issa, Rochell , Calcagno, Tess , Canova, Tyler , Issa, Ryan, Menon, Venu , Griffin, Brian P. , Kwon, Deborah , Wang, Tom Kai Ming , Wang, Tom Kai Ming , Kaelber, David C. , Tang, W.H. Wilson

Angiology | August 25, 2025 | Volume: 77 | Issue: 6 | Pages: 704-713

10.1177/00033197251365016 | PMID 40852947 Get It

This retrospective propensity-matched cohort study assessed the association between sodium-glucose co-transporter-2 inhibitor (SGLT2i) use and cardiovascular outcomes in patients with acute myocardial infarction (AMI) without a history of heart failure. Using the TriNetX U.S. Collaborative Network, we identified 1440 matched patients (720 SGLT2i+ vs 720 SGLT2i−) with preserved ejection fraction and no prior heart failure. Nearly 90% of patients had diabetes. The primary outcome was major adverse cardiovascular events (MACE), defined as a composite of MI, stroke, heart failure, and all-cause mortality. At 1 year, MACE occurred in 17.4% of SGLT2i+ versus 22.0% of SGLT2i− patients (odds ratio [OR] 0.746, 95% CI 0.574-0.969; P = .028), and all-cause mortality occurred in 3.1% versus 7.6%, respectively (OR 0.389, 95% CI 0.234-0.645; P < .001). SGLT2i use was also associated with lower risks of major bleeding. Findings were consistent over long-term follow-up. While the observed associations suggest potential cardioprotective effects of SGLT2i post-MI in patients without heart failure, residual confounding cannot be excluded. The observed reduction in bleeding events is novel and warrants further investigation in prospective studies.